Debbie L Hay
Debbie L Hay
School of Biological Sciences, University of Auckland
Verified email at
TitleCited byYear
Oxyntomodulin inhibits food intake in the rat
CL Dakin, I Gunn, CJ Small, CMB Edwards, DL Hay, DM Smith, ...
Endocrinology 142 (10), 4244-4250, 2001
GPCR modulation by RAMPs
DL Hay, DR Poyner, PM Sexton
Pharmacology & therapeutics 109 (1-2), 173-197, 2006
The concise guide to PHARMACOLOGY 2015/16: Overview
SPH Alexander, E Kelly, N Marrion, JA Peters, HE Benson, E Faccenda, ...
British journal of pharmacology 172 (24), 5729-5743, 2015
The concise guide to pharmacology 2017/18: overview
SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ...
British journal of pharmacology 174, S1-S16, 2017
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes
DL Hay, G Christopoulos, A Christopoulos, DR Poyner, PM Sexton
Molecular pharmacology 67 (5), 1655-1665, 2005
The concise guide to PHARMACOLOGY 2013/14: overview
SPH Alexander, HE Benson, E Faccenda, AJ Pawson, JL Sharman, ...
British journal of pharmacology 170 (8), 1449-1458, 2013
CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22–52, CGRP8–37 and…
DL Hay, SG Howitt, AC Conner, M Schindler, DM Smith, DR Poyner
British journal of pharmacology 140 (3), 477-486, 2003
Amylin: pharmacology, physiology, and clinical potential
DL Hay, S Chen, TA Lutz, DG Parkes, JD Roth
Pharmacological reviews 67 (3), 564-600, 2015
Regulation of signal transduction by calcitonin gene-related peptide receptors
CS Walker, AC Conner, DR Poyner, DL Hay
Trends in pharmacological sciences 31 (10), 476-483, 2010
The pharmacology of adrenomedullin 2/intermedin
Y Hong, DL Hay, R Quirion, DR Poyner
British journal of pharmacology 166 (1), 110-120, 2012
Interaction of calcitonin-gene-related peptide with its receptors
AC Conner, DL Hay, SG Howitt, K Kilk, Langel, M Wheatley, DM Smith, ...
Biochemical Society Transactions 30 (4), 451-455, 2002
International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor
DL Hay, DR Poyner, R Quirion
Pharmacological reviews 60 (2), 143-145, 2008
Amylin receptors: molecular composition and pharmacology
DL Hay, G Christopoulos, A Christopoulos, PM Sexton
Biochemical Society Transactions 32 (5), 865-867, 2004
Adrenomedullin receptors: molecular identity and function
DL Hay, DM Smith
Peptides 22 (11), 1753-1763, 2001
Complexing Receptor Pharmacology: Modulation of Family BG Protein–Coupled Receptor Function by RAMPs
PM Sexton, M Morfis, N Tilakaratne, DL Hay, M Udawela, G Christopoulos, ...
Annals of the New York Academy of Sciences 1070 (1), 90-104, 2006
Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl] carbonyl] pentyl] amino]-1-[(3, 5-dibromo-4-hydroxyphenyl) methyl]-2-oxoethyl]-4-(1…
DL Hay, G Christopoulos, A Christopoulos, PM Sexton
Molecular pharmacology 70 (6), 1984-1991, 2006
The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors
DL Hay, AC Conner, SG Howitt, DM Smith, DR Poyner
Journal of Molecular Neuroscience 22 (1-2), 105-113, 2004
Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development
JK Archbold, JU Flanagan, HA Watkins, JJ Gingell, DL Hay
Trends in pharmacological sciences 32 (10), 591-600, 2011
A second trigeminal CGRP receptor: function and expression of the AMY1 receptor
CS Walker, S Eftekhari, RL Bower, A Wilderman, PA Insel, L Edvinsson, ...
Annals of clinical and translational neurology 2 (6), 595-608, 2015
Differential activation of G‐proteins by μ‐opioid receptor agonists
Z Saidak, K Blake‐Palmer, DL Hay, JK Northup, M Glass
British journal of pharmacology 147 (6), 671-680, 2006
The system can't perform the operation now. Try again later.
Articles 1–20